FindTrial
Sign In

Plain aspirin

DRUG3 trials

Sponsors

Royal College of Surgeons, Ireland, Hamad Medical Corporation, Rajaie Cardiovascular Medical and Research Center

Conditions

Atherosclerotic Cardiovascular DiseaseCardiovascular DiseaseCarotid Artery StenosisCarotid AtherosclerosisCoronary Artery DiseaseIschemic Heart DiseaseIschemic StrokePeripheral Arterial Disease

Phase 4

An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke.
CompletedNCT04330872
Hamad Medical CorporationStroke, Ischemic
Start: 2019-08-26End: 2020-03-04Updated: 2020-04-02

Unknown Phase

Enteric Coating as a Factor in Aspirin Resistance
CompletedNCT00531362
Royal College of Surgeons, IrelandCardiovascular Disease
Start: 2007-09-30End: 2008-12-31Updated: 2009-09-29
Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease
RecruitingNCT06541691
Rajaie Cardiovascular Medical and Research CenterAtherosclerotic Cardiovascular Disease, Carotid Artery Stenosis, Carotid Atherosclerosis +4
Start: 2024-03-06End: 2027-03-30Target: 3000Updated: 2025-03-19

Related Papers

The impact of enteric coating of aspirin on aspirin responsiveness in patients with suspected or newly diagnosed ischemic stroke: prospective cohort study: results from the (ECASIS) study
European Journal of Clinical Pharmacology2022-09-195 citations
An investigation into the impact of enteric coated of aspirin in patients with newly diagnosed ischemic stroke (ECASIS)
Medicine2020-05-15